key: cord-0336301-puf6e3mt
authors: Gupta, Aayush; Zhou, Huan-Xiang
title: A Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening
date: 2021-06-20
journal: bioRxiv
DOI: 10.1101/2021.06.20.449177
sha: 4e2369c04d19e9f0877defe6e66bdbf4a1e37016
doc_id: 336301
cord_uid: puf6e3mt

Virtual screening is receiving renewed attention in drug discovery, but progress is hampered by challenges on two fronts: handling the ever increasing sizes of libraries of drug-like compounds, and separating true positives from false positives. Here we developed a machine learning-enabled pipeline for large-scale virtual screening that promises breakthroughs on both fronts. By clustering compounds according to molecular properties and limited docking against a drug target, the full library was trimmed by 10-fold; the remaining compounds were then screened individually by docking; and finally a dense neural network was trained to classify the hits into true and false positives. As illustration, we screened for inhibitors against RPN11, the deubiquitinase subunit of the proteasome and a drug target for breast cancer. TOC Graphic

The last decade has seen a dramatic increase in the popularity of virtual screening in drug discovery, driven in large part by the ever expanding universe of drug-like molecules and by advances in computational technology [1] [2] [3] [4] [5] . However, real progress is hampered by challenges on two fronts. First, the number of readily available commercial compounds will soon reach 10 11 to 10 12 molecules 6 , while some estimates put the number of drug-like molecules at > 10 60 7 . Docking such astronomical numbers of compounds to a given drug target is a formidable task. Second, docking is good at screening out inactive compounds but produces an excessive number of false positives 2, 7, 8 . The present study was designed to achieve breakthroughs on both of these fronts.

One strategy to tackle an astronomical number of compounds is library trimming, if it is done without losing potential hits. Compound clustering is a promising approach, whereby one can either select a fraction of the clusters that are most likely to contains hits, or select a representative subpopulation for each cluster so to preserve the diversity of the full library. Two practical problems have to addressed: what features to use for clustering and how to cluster. Features have to capture essential physicochemical properties of compounds but also be readily available. These properties, including logP and number of aromatic rings, are now retrievable from websites such as ZINC15 (https://zinc15.docking.org/) 9 or easily produced by computer software such as the RDKit package 10 , and are starting to be used for compound clustering 11 . Machine learning-based algorithms such as hierarchical clustering 12 and k-means clustering 13 have been shown to be powerful in drug discovery applications [14] [15] [16] , but to the best of our knowledge have not been used for library trimming. Other approaches to library trimming include regression models 17 .

Machine learning also holds promises in classifying compounds into positives and negatives, or separating docking-selected hits into true and false positives 8, [18] [19] [20] [21] [22] [23] [24] [25] [26] . For example, vScreenML 8 was a decision-tree based classifier, trained on a dataset mixing ~4000 decoys with ~1400 ligands extracted from complexes in the Protein Data Bank (PDB). The input was 68 features representing protein-ligand interactions and ligand descriptors. Other classifiers employed neural networks, including NNscore 19 , DLscore 22 , Pafnucy 23 , and OnionNet 24 . Metamethods, based on the consensus of different classifiers, are also emerging 26 .

Increasingly, molecular dynamics (MD) simulations have been used to reject false positives from docking [27] [28] [29] [30] . Even though much more expensive than docking, the potential of classical MD simulations is still limited by the capability of molecular mechanics (MM) force fields in modeling the interactions and sampling the poses of protein-drug complexes. Quantum mechanics provides an accurate description of molecules and hybrid QM/MM modeling provides a powerful tool for studying protein-drug complexes 31 . Our previous work has demonstrated the success of QM/MM MD simulations in selecting inhibitors against the SARS-CoV-2 main protease M pro 32 . The QM force field was ANI-2x 33 , which was trained by a neural network on millions of small molecules against density functional theory energies. Our ANI/MM MD simulations formed the end stage of a workflow for drug discovery. The workflow started with docking 1615 FDA-approved drugs against M pro . The docking hits were further filtered, first by classical MD simulations and then by ANI/MM MD simulations, finally predicting 9 M pro inhibitors, of which at least 3 are reported as active in the literature.

Here we report a machine learning-enable pipeline for large-scale virtual screening. The two core components of the pipeline are (1) library trimming by clustering; and (2) separation of dockingselected hits into true and false positives by a dense neural network (DNN). We illustrate this pipeline by screening for inhibitors against RPN11, the deubiquitinase subunit of the proteasome ( Fig. 1 ) and a drug target for breast cancer 34, 35 . We adapted our previous workflow 32 to produce 8 RPN11 inhibitors. In comparison, with significantly reduced computing cost, machine learningenable pipeline picked up 6 of these inhibitors. base, and core particle. The lid contains a non-redundant enzymatic activity, encoded by the RPN11 deubiquitinase. A chain of red circles represents the polyubiquitin tag, which RPN11 must first cleave from the substrate protein (orange oval). The substrate protein is then unfolded (orange curve) and enters the core particle, where it undergoes proteolysis (broken orange pieces). RPN11 is shown with the catalytic site zoomed.

Preparation of RPN11 structure. RPN11 was taken from chain 15 (non-ATPase regulatory subunit 14) of PDB entry 5GJR, which is a cryo-EM structure of the human proteasome 36 . Missing residues 1-27 and 164-189 were built by Modeller 37 ; residues outside the catalytic core domain (up to Ser224) were trimmed. The missing Zn 2+ ion at the catalytic site was transferred from another deubiquitinylase, CSN5 (the proteolytic subunit of the COP9 signalosome; PDB entry 5JOG 38 ), by aligning the respective catalytic sites 39 . The Ins-1 loop (residues 76-88) was modeled with 20 conformations that were generated by the RCD+ server 40 and left the active site exposed. 45 . Each RPN11-ligand complex was placed in a triclinic box and solvated with TIP3P water model 46 . Na + and Cl − were added to neutralize the system and provide salt at 0.15 M concentration. After 5000 steps of steepest-descent minimization, the system was equilibrated first at constant NVT (1 ns) and then at constant NPT (2 ns), with the solute under position restraint.

Temperature (310 K) and pressure (1 bar) were controlled by Langevin dynamics 47 . Long-range electrostatic interactions were treated using the particle mesh Ewald method 48 . The production run was 100 ns at constant NPT without restraints.

For classifying whether a ligand was a positive or a negative, the average ligand-root-mean-squaredeviation (ligand-RMSD) was calculated over 8000 snapshots evenly sampled from 20 ns to 100 ns of the production run, with the 20-ns snapshot (C only) as reference for RPN11 superposition.

We also calculated MM/PBSA binding free energy 49 over 2000 snapshots from 80 to 100 ns. To prepare a training set for the DNN, we also ran shorter MD simulations (10 ns production). Here ligand-RMSD was calculated over 800 snapshots sampled from 2 to 10 ns.

Hybrid ANI/MM MD simulations were as described in our previous work 32 . Force field settings for the protein and solvent were as stated above for classical simulations, that for ligands was ANI-2x 33 . Starting with the final snapshot (at 100 ns) of the classical MD simulation, we ran 5 ns of ANI/MM MD simulations. 2500 snapshots were sampled to calculate ligand-RMSD, with the first snapshot as reference; 500 evenly spaced snapshots were used to calculate MM/PBSA binding free energy.

Clustering Analyses. Compound clustering was based on five molecular properties: logP, HBD, HBA, Ring, and RB. These have been used in a recent study for clustering of 197 ligands of the SARS-CoV-2 main protease 11 . Extraction of these features for millions of compounds was carried out by scraping the ZINC15 website 9 , using the Requests module of python (https://pypi.org/project/requests/) for sending HTTP queries and Beautiful Soup module (https://pypi.org/project/beautifulsoup4/) for parsing HTML documents.

For clustering the 101 compounds selected by the level-1 docking, we used agglomerative hierarchical clustering 12 . For a library containing millions of compounds, we used k-means clustering 13 to reduce computational complexity. We used the scikit-learn libraries (https://scikitlearn.org/stable/modules/clustering.html#clustering) and wrote python scripts for implementation. neurons, each with one feature as input. The output layer had a single neuron, with the output value ranging from 0 to 1 and representing the probability of a true positive prediction. A threshold of 0.5 was set for a true positive prediction. Between the input and output layers, the DNN had four fully connected hidden layers that contained 1000, 500, 100, and 10 neurons, respectively, each with a dropout layer (at a dropout rate of 0.3) to prevent overfitting. All neurons but one had a rectifier activation function; the output neuron had a sigmoid activation function.

We first adapted the workflow developed in our previous study 32 to screen for inhibitors of RPN11. This workflow involved docking 2.4 million compounds and evaluating hits by expensive classical and hybrid quantum/classical MD simulations, leading to 8 true positives ( Fig. 2A) . We then developed a machine learning-enabled pipeline, where the library was trimmed 10-fold before docking, and a DNN was trained to separate true positives from false positives. 

Autodock Vina 41 to dock each of the 2.4 million compounds, with dock-ready chemical structures extracted from the ChemDiv and Asinex libraries at the ZINC15 website (https://zinc15.docking.org/) 9 , to a rigid structure of RPN11. In this "level-1" docking, for each compound, 10 conformations generated by the rotation of torsion angles were tested, and the one with the best Vina score was reported. The compounds were ranked according to Vina scores (with the best score at -10.4 kcal/mol), and a cutoff of -9.2 kcal/mol was applied to select 101 compounds.

Next to the active site of RPN11 is a loop (residues 76-88) known as Ins-1. This flexible loop is very important for regulating enzymatic activity and changes conformation upon ligand binding 52, 53 . We thus generated 19 additional conformations for the Ins-1 loop (Fig. S1) Table S1 ). Similar to our previous work on the SARS-CoV-2 main protease 32 , the ANI/MM MD simulations improved the binding free energies (as calculated by the MM/PBSA method 49 ) for a majority (5 out of 8) of the true positives, but eroded the binding free energies for a majority (9 out of 11) of the false positives (Fig. 2C, bottom portion) . Next we use the foregoing results for RPN11 to illustrate the design of our machine learning-enabled pipeline for large-scale virtual screening and to assess its accuracy.

Trimming of the full library by k-means clustering. The basic idea behind our library trimming was to cluster the compounds and select the smallest number of clusters that contained the largest number of positives. For this idea to work, the positives themselves have to form a small number of clusters; otherwise a large number of clusters has to be retained, defeating the purpose of library trimming. In addition, one has to use appropriate features for the clustering to be effective. Here we chose five molecular properties that we dub PDARB: logP (where P denotes partition coefficient), number of hydrogen bond donors (HBD), number of hydrogen bond acceptors (HBA), number of aromatic rings (Ring), and number of rotatable bonds (RB).

We were able to extract PDARB from the ZINC15 website 9 for 97 of the 101 ligands selected by the level-1 docking (Fig. 3A) . For the remaining 4 ligands, we obtained PDARB using the RDKit package 10 . By hierarchical clustering based on distances calculated on PDARB, the 101 ligands fell into as few as 3 clusters, with 25, 48, and 28 ligands, respectively (Fig. 3B) . By inspecting 2dimensional (2D) structures and physicochemical properties, we verified that ligands in the same cluster are similar but those in different clusters are distinct ( Fig. 3A & C) . Cluster I is high in HBD and RB; cluster II is high in logP but low in HBD; and cluster III is high in HBA and Ring.

This pilot study thus verified that positives selected by docking indeed form a small number of clusters and PDARB is effective for clustering. We then tried to extract PDARB from the ZINC15 website 9 for the 2.4 million compounds in our initial library, and succeeded for 1.3 million compounds. To these we also added the 4 ligands with PDARB from RDKit, so the entire selection of 101 ligands from the level-1 docking were present in the full library of 1.3 million compounds, allowing us to better design and assess the library trimming protocol. We set a goal of 10-fold trimming and used k-means for clustering the compounds (Fig. 4A ).

The first step was to find the optimal number ("k") of clusters. To that end, we clustered the 1. Next, with k = 100, we selected 10 or so (i.e., 10% of k) clusters based on the Vina scores of a few ligands from each cluster. Specifically, in each cluster, we picked the 10 ligands closest to the cluster centroid and obtained their Vina scores ("limited" docking; Fig. 4 A & B) . We then tuned a cutoff for Vina scores for cluster selection. A cluster was selected when the best Vina score among the 10 ligands was lower than the cutoff. With cutoffs at -8.0, -7.9, and -7.8 kcal/mol, the number of clusters selected was 7, 11, and 12, respectively. The middle cutoff (i.e., -7.9 kcal/mol) yielded the cluster number closest to our target value of 10 To assess whether combining subsets A and B boosted accuracy, we also evaluated accuracy when the DNN was trained on subset A or B only. Each subset was again split at a 6:4 ratio for training and validation. When trained with subset A only, the accuracy was 60.9%, which is one percentage point lower than that when subsets A and B were combined for training. Therefore including subset B in training indeed boosts the accuracy for separating true and false positives.

We also benchmarked our DNN against other neural network-based methods for separating true and false positives. As stated above, our accuracy, as evaluated on subset A, was 61.8%. The classification accuracies for the entire subset A (824 ligands) based on Vina scores and by OnionNet 24 , NNscore 19 , DLscore 22 , and Pafnucy 23 were 53.7%, 51.6%, 53.5%, 54.0%, and 55.4%, respectively (Fig. S3) . A null model where 523 ligands were randomly picked as true positives and the remaining 301 ligands as false positives has an accuracy of 53.6%. So most of these alternative methods were no better than the null model; only Pafnucy performed slightly better than the null model, by 1.8 percentage points. Our DNN significantly outperformed these alternative methods. 

We have developed a machine learning-enabled pipeline for large-scale virtual screening that addresses two major current challenges (Fig. 6) . By trimming the full library of compounds, docking can be focused on a small fraction that are most likely to contain hits. By training a dense neural network, most of the false positives from docking can be rejected. We have illustrated this pipeline on the RPN11 target, but the same design and the underlying ideas can be used to screen large libraries against other drug targets.

In our particular application of the machine learning-enabled pipeline, we trimmed a library of 1.3 million compounds by 10-fold without losing any true positives. The same clustering approach can be applied much more aggressively to trim libraries of billions of compounds. The five features used for clustering, logP, HBD, HBA, Ring, and RB, are readily available and seem to be very effective. It will be of continued interest to explore other features for clustering. Our trimming here was based on selecting a small number of entire clusters. A complementary approach is library dilution, by selecting a representative subpopulation for each cluster so to preserve the diversity of the full library.

In training our DNN, we used MD simulations of relatively short length (i.e., 10 ns). By allowing the protein and ligand molecules to move in an explicit solvent, either to form more stable poses or to escape from artificially constructed poses in docking, even such short MD simulations have significant capability in discriminating true positives from false positives. This capability becomes especially powerful when accumulated over a large number of compounds (852 in our case) and learned by a dense neural network. Indeed, of the 44 compounds selected by the level-2 docking and evaluated by 100-ns MD simulations, classification based on the 10-ns simulations of the docked complexes of these 44 compounds alone had only an accuracy of 50%. However, by using the DNN, the accuracy increased to 68.1%. RPN11 inhibition prevents the proteolysis of a subset of polyubiquitinated protein substrates and is emerging as a new proteosome-targeting therapy against breast cancer by perturbing protein homeostasis 34, 35 . Here by hybrid ANI/MM MD simulations, we have identified 8 new compounds as potential RPN11 inhibitors (Table S1 ). We hope that these compounds will be evaluated by biochemical assays and our machine learning-based pipeline will assist the development of drug therapies targeting RPN11 and other proteins.

All MD simulations were carried out on a GPU cluster running NAMD. Scikit-learn was used to build clustering models and Keras with Tensorflow backend was used to develop the DNN. A workstation with 8 cores (Intel(R) Xeon(R) CPU E3-1240 v6 @ 3.70 GHz processor), 16 GB of RAM, and Nvidia Quadro P1000 GPUs was used for training/prediction. The implementation codes, saved DNN model, tutorials, and example data are available on GitHub:

https://github.com/aaayushg/RPN11_inhibitors.

Huan-Xiang Zhou (email: hzhou43@uic.edu)

Virtual screening: an endless staircase?

Beware of docking!

Docking Screens for Novel Ligands Conferring New Biology

Past, Present, and Future of Molecular Docking

Current Trends, Overlooked Issues, and Unmet Challenges in Virtual Screening

ZINC20-A Free Ultralarge-Scale Chemical Database for Ligand Discovery

Ultra-large library docking for discovering new chemotypes

Machine learning classification can reduce false positives in structure-based virtual screening

ZINC 15--Ligand Discovery for Everyone

Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro

Efficient Algorithms for Agglomerative Hierarchical Clustering

Constrained K-means Clustering with Background Knowledge

A hierarchical clustering approach for large compound libraries

Clustering of chemical data sets for drug discovery

ChemBioServer 2.0: an advanced web server for filtering, clustering and networking of chemical compounds facilitating both drug discovery and repurposing

Lean-Docking: Exploiting Ligands' Predicted Docking Scores to Accelerate Molecular Docking

Automatic clustering of docking poses in virtual screening process using self-organizing map

NNScore 2.0: a neural-network receptor-ligand scoring function

Integrated machine learning, molecular docking and 3D-QSAR based approach for identification of potential inhibitors of trypanosomal N-myristoyltransferase

Incorporating Protein Dynamics Through Ensemble Docking in Machine Learning Models to Predict Drug Binding

A Deep Learning Model for Predicting Protein-Ligand Binding Affinities. ChemRxiv

Development and evaluation of a deep learning model for protein-ligand binding affinity prediction

OnionNet: a Multiple-Layer Intermolecular-Contact-Based Convolutional Neural Network for Protein-Ligand Binding Affinity Prediction

Integrating Machine Learning-Based Virtual Screening With Multiple Protein Structures and Bio-Assay Evaluation for Discovery of Novel GSK3beta Inhibitors

True Accuracy of Fast Scoring Functions to Predict High-Throughput Screening Data from Docking Poses: The Simpler the Better

High-performance drug discovery: computational screening by combining docking and molecular dynamics simulations

Exploring the Stability of Ligand Binding Modes to Proteins by Molecular Dynamics Simulations: A Cross-docking Study

Applying Pose Clustering and MD Simulations To Eliminate False Positives in Molecular Docking

Protein structure-based drug design: from docking to molecular dynamics

NAMD goes quantum: an integrative suite for hybrid simulations

Profiling SARS-CoV-2 Main Protease (M(PRO)) Binding to Repurposed Drugs Using Molecular Dynamics Simulations in Classical and Neural Network-Trained Force Fields

Extending the Applicability of the ANI Deep Learning Molecular Potential to Sulfur and Halogens

Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11

Epidithiodiketopiperazines Inhibit Protein Degradation by Targeting Proteasome Deubiquitinase Rpn11

An atomic structure of the human 26S proteasome

Protein structure modeling with MODELLER

Targeted inhibition of the COP9 signalosome for treatment of cancer

Computational Studies on the Inhibitor Selectivity of Human JAMM Deubiquitinylases Rpn11 and CSN5

RCD+: Fast loop modeling server

Computational protein-ligand docking and virtual drug screening with the AutoDock suite

Open Babel: An open chemical toolbox

Scalable molecular dynamics with NAMD

Zinc binding in proteins and solution: a simple but accurate nonbonded representation

SwissParam: a fast force field generation tool for small organic molecules

A modified TIP3P water potential for simulation with Ewald summation

Constant pressure molecular dynamics simulation: The Langevin piston method

A smooth particle mesh Ewald method

CaFE: a tool for binding affinity prediction using end-point free energy methods

TensorFlow: A system for large-scale machine learning

PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints

Insights into the regulation of the human COP9 signalosome catalytic subunit, CSN5/Jab1

Structure of the Rpn11-Rpn8 dimer reveals mechanisms of substrate deubiquitination during proteasomal degradation

We thank Dr. Xing Che for assistance in preparing the RPN11 structure for docking. This work was supported by National Institutes of Health Grant GM118091.

The authors declare no competing financial interests.

Figures S1-S3 and Table S1 References